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Pregnancy-specific glycoproteins (PSGs) are fetal proteins secreted by the
placenta during pregnancy. The PSG level in maternal serum is an indica-
tor of risk for pregnancy complications. However, little is known about the
molecular mechanisms underlying PSG gene expression. Recently, the
importance of epigenetic regulation of placental genes has been emphasized
in the study of developmental defects and placental disease. In this study,
the role of the CCCTC-binding factor (CTCF) in regulation of PSG
expression was investigated to better understand the epigenetic regulatory
mechanisms of the PSG genes. Inhibition of CTCF expression disturbed
transcription of several PSG genes: PSG1, PSG2, PSG4, PSG5, PSG8, and
PSG9 were upregulated and PSG6 and PSG11 were downregulated. These
transcriptional changes were correlated with decreased CTCF binding and
changes in histone modification at the PSG promoters. Our data demon-
strate that CTCF is a potential mediator in the regulation of PSG gene
expression.
Pregnancy-specific glycoproteins (PSGs) are the mem-
bers of the carcinoembryonic antigen family, one of
immunoglobulin super families. PSG genes are clus-
tered on chromosome 19q13.2 encoding 10 genes in
humans and chromosome 7 comprising 17 genes in
mice [1]. Human PSGs are expressed in the syncy-
tiotrophoblast of the placenta and secreted into the
maternal bloodstream. PSGs are among the most
abundant fetal proteins detected in the maternal circu-
lation produced by the placenta during pregnancy [2].
The known functions of PSG during pregnancy are
implicated in immune regulation, angiogenesis, and
platelet regulation, which are important for normal
placental development [3–5]. Defects in placental
development are directly associated with the disruption
of the maintenance of pregnancy [6]. In particular,
several case–control studies have shown that low levels
of PSG are associated with complicated pregnancy
outcomes such as intrauterine growth retardation
(IUGR), preterm labor, and pre-eclampsia (PE) [7–9].
These reports imply the pivotal roles of PSG in suc-
cessful pregnancy outcomes; however, the molecular
mechanism underlying the regulation of PSG gene
expression is not well understood.
During development, epigenetic changes modulate
the accessibility of transcription factors to the DNA
and consequently affect gene expression. Epigenetic
mechanisms during development include DNA methy-
lation, histone modifications, the action of non-coding
RNAs, and 3D structural changes in the chromatin,
all of which affect cell phenotype and function and
contribute to the associated pathological conditions
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[10]. Many recent studies have shown that epigenetic
modifications are related to placental development and
disease during pregnancy [11–14]. Appropriate placen-
tation and fetal environment are not only important
for the intrauterine growth and survival of the fetus
but also affect neurodevelopmental disease and meta-
bolism in the postnatal phase through a process called
fetal reprogramming [15]. Under pathologic conditions
such as PE, IUGR, and small for gestational age, epi-
genetic dysregulation correlates with abnormal placen-
tal gene expression [16]. It is, therefore, imperative to
understand the expression pattern of placental genes
and their epigenetic regulatory mechanisms to eluci-
date the causal relationship between placental develop-
ment and disease during pregnancy and for the
development of preventive measures or treatment regi-
mens.
Among the epigenetic modifiers, the CCCTC-bind-
ing factor (CTCF) is a highly conserved, and ubiqui-
tously expressed DNA-binding protein. CTCF
regulates gene transcription as an activator, a repres-
sor, or an insulator and serves as a core chromatin
organizer by contributing to establishing the three-di-
mensional structure of the genome [17]. Abnormal
CTCF binding to the DNA-binding sites may perturb
appropriate long-range chromatin interactions, thereby
regulating genomic instability [18]. Many studies have
shown that abnormal CTCF binding may cause distur-
bances in the transcriptional regulation of tumor sup-
pressors or oncogenic genes in many human cancers.
CTCF also regulates embryonic development by affect-
ing the expression of several genes that influence cell
survival and proliferation (reviewed in [19]). Specifi-
cally, CTCF has been demonstrated to regulate the
clustered gene families such as HOX, protocadherin,
and b-globin through the organization of chromatin
structures [20–22]. DNA methylation, which is
involved in a wide range of gene expression during
development and disease, is known to affect the
CTCF-DNA binding occupancy [23]. A study showing
the disruption of endothelial vascular development in
the placenta of CTCF-deficient mice demonstrates the
importance of CTCF for adequate placentation to
facilitate normal fetal development [24].
To date, no study has reported the association
between CTCF and regulation of PSG gene expres-
sion. In the present study, we investigated whether
CTCF binding, which is highly conserved across the
PSG loci, contributes to the regulation of PSG gene
expression in trophoblast cells. Further understanding
of the mechanisms underlying PSG gene regulation
will lay the scientific foundation for the development
of diagnostics and therapeutics for placental disease.
Materials and methods
Cell culture and transfection
The human extravillous trophoblast cell line Swan 71 was
kindly provided by J.-Y. Kwon (Institute of Women’s Life
Medical Science, Yonsei University Health System, Seoul,
Korea). These cells were cultured in Dulbecco’s modified
Eagle’s medium (WELGENE Inc., Daegu, Korea) supple-
mented with 10% FBS (WELGENE Inc.), 19 antibiotic-
antimycotic solution (WELGENE Inc.), 19 HEPES buffer
solution (WELGENE Inc.), and 19 non-essential amino
acid solution (WELGENE Inc.) in humidified air at 37 °C
and 5% CO2. For gene knockdown (KD) study, Swan 71
cells were seeded at 1 9 106 cells in 100 mm culture plate
and were transfected with 10 nM of siRNA using G-fectin
(Genolution, Seoul, Korea) for 48 h. ON-TARGET plus
CTCF siRNA (L-020165-00-0005) were purchased from
Dharmacon (Cambridge, UK), which utilizes a patented
dual-strand modification to reduce off-target effects. Nega-
tive control siRNA (sense sequence, 50-CCUCGUGCC-
GUUCCAUCAGGUAGUU-30; antisense sequence, 50-
CUACCUGAUGGAACGGCACGAGGUU-30) was pro-
vided by Genolution Inc.
Total RNA isolation and reverse-transcription
PCR
Total RNA from cultured cells was extracted using Trizol
reagent (Invitrogen, CA, USA) according to the manufac-
turer’s instructions. cDNA synthesis was performed with
1 lg of total RNA using ImProm-II Reverse Transcriptase
(Promega, Madison, WI, USA) and RNase inhibitor (Pro-
mega). Since the nucleotide sequence of all PSG genes is very
similar, the primer design process and PCR conditioning
were carefully adjusted to guard against off-target priming.
PCR conditions for amplification of PSG cDNAs were as
follows. An initial denaturation step was done at 95 °C for
10 min, followed by 30–42 cycles of denaturation at 95 °C
for 40 s, annealing at 58 °C for 20 s, and extension at 72 °C
for 30 s. The final extension step was done at 95 °C for
5 min. After confirming that the PCR products of all PSG
genes appeared as a single band with the correct size, RT-
qPCR was performed. For RT-qPCR, cDNA was amplified
using SYBR Green PCR Master Mix (Applied Biosystems,
Carlsbad, CA, USA) on an ABI7300 real-time PCR system
(Applied Biosystems). PCR primers are listed in Table 1.
ChIP assay
Swan 71 cells were harvested at 80–90% confluency with
0.7 9 106 cells per antibody. The cells were cross-linked
with 1% formaldehyde using 37% formaldehyde for
15 min at room temperature. To quenching the reaction,
2.5 M glycine was added to make 125 mM for 10 min at
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room temperature. Then, cells were washed twice with 19
cold PBS and lysed in lysis buffer for 10 min on ice. Lysis
buffer consisting of 1% SDS, 1% Triton X-100, 0.1%
sodium deoxycholate, 10 mM EDTA, 50 mM Tris–HCl (pH
8.0), and a protease inhibitor (Merck, Darmstadt, Ger-
many) was added. Sonication sheared 500–1000 bp DNA
fragments, which is confirmed by loading with 1% agarose
gel. Then, the lysates were incubated with Protein A/G
PLUS-Agarose (Santa Cruz, Dallas, TX, USA) in a rotator
for 1 h at 4 °C. For DNA-protein complexes, precleared
DNA is incubated with antibody overnight at 4 °C. ChIP-
grade anti-CTCF antibody (Cell Signaling Technology,
Beverly, CA, USA), normal rabbit IgG (Santa Cruz), anti-
PolⅡ (Santa Cruz), anti-histone H3 trimethyl K4 (Abcam,
Cambridge, UK), and anti-histone H3 trimethyl K27
(Abcam) were used.
ChIP-seq database
Bioinformatic analyses for CTCF binding sites (CBSs) were
performed using the University of California Santa Cruz
(UCSC) genome browser (https://genome.ucsc.edu/). The
ChIP-seq data for four cell lines represented in Fig. 1A can
be accessed using the following codes: HeLa-S3,
GSM749729; h1 human embryonic stem cell (H1-hESC),
GSM733672; human umbilical vein endothelial cell
(HUVEC), GSM749749, and human villous mesenchymal
fibroblast (HVMF), GSM1022630.
Statistical analysis
Data were obtained from three separate experiments and
represented as mean  standard error of the mean (SEM).
The Student’s t-test was used for comparison between
siCTCF-treated cells and control. Differences were statisti-
cally significant at P < 0.05.
Results and Discussion
The binding of CTCF to the DNA is determined by
the recognition of the consensus sequence; some bind-
ing sites exhibit differential CTCF binding patterns
depending on the tissues, while others consistently
show strong binding to CTCF in most tissues. CBSs
distribute all throughout the genome, that is, inter-
genic region, gene bodies, and promoters, and its role
is determined by where the CTCF binds [25]. Before
Table 1. Primer sequences for RT-PCR and ChIP-PCR.
Primer sequences for qRT-PCR
Forward primer (50–30) Reverse primer (50–30)
PSG1 GAG CTT GAG AAT TGC TCC TGC GAG GGG CTG AGA GGG TTC
PSG2 CCA CCC ATG AGC CTG GGA AT CCA GGA GCC CCT TCC ATT TGA TGT
PSG3 GGC AGA CAG TTG CTT TCA TTC TT TTC TGG GGC ACT TAG GGA GC
PSG4 CAT GTG AGC CAC TCA GAA CTC A TAA GAG GGG TGG GAG CCT TA
PSG5 CCT GGA GAG AGG CTC AGC A CAG GGC TTC AAT CGT GAC TTG
PSG6 ACT TAA ACC CCA GGG AGA AG GTT TCC ATG GCA GGG ACC A
PSG7 TCC GTG ACA GTC AGA GTC TC CTG ACT TAT AGG GCT TCT GG
PSG8 CAA GCC CTA CAT CAC CAT CAA C GAT GCC ACC ATA TTG GTC CCT T
PSG9 TCC TGC ACA CAG CGC ATC GGT GTA GGT TCC TGC ATC CTT
PSG11 GTC TCA GCG CAG AAG GAG G CCA TTT GAT GTG CTC TGT GC
b-actin CAT GTT TGA GAC CTT CAA CAC CCC GCC ATC TCC TGC TCG AAG TCT AG
Primer sequences for ChIP-PCR
Forward primer (50–30) Reverse primer (50–30) Position from TSS
PSG1-up TGG AAT TGC TGC CGT TCA CAC TCA CGA GGG GAA AGC ACC CG 1427 to  1751
PSG2-up GAG GTC AGG AGG GGA AAG CT GTG TGA AGT GTG CAG ATC CAC A 1361 to  1755
PSG3-up GCT GGA AGG TGA AGG AGC TA TTA GGG AGC AGT GAC AGA AC 1354 to  1827
PSG4-up AGG TCA CGA GGG GAA AGC GT GTC ACA CAG ACT GGG ACT CAA 1279 to  1737
PSG5-up AGG AGC AGG TGT GTG GGG CT CGT GTG AAG TGT GCA GAT CCA T 1464 to  1777
PSG6-up GAG CTA CCT GCA GAG GGC CTG CCT TTG GGA CAT CTG AC 1493 to  1900
PSG7-up CAG CTC TAG GCT TCA CCT GC ACA CTT CCC TCC CTG TCC AA 1344 to  1776
PSG8-up CAC GAG GGG AAA GCG CCT CGT GTG AAG TGT GCA GAT CCA T 1461 to  1850
PSG9-up GAC CTC GTG TGA AGT GGA ATA A GGA AGG AGC AGG TGT GTG G 1486 to  1793
PSG11-up AGG AAC TAC CTG TAG GGG GA GTG AAG TGT GCA GAT CCA CGT A 1520 to  1811
Gene desert TGT TTT TGC AGT TAC TAG ACT GGG TT CCC CTG CTT TTA TGT GG
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exploring the role of CTCF as a PSG gene regulator
in trophoblast cells, we first examined the CTCF bind-
ing patterns across the PSG gene loci using publicly
available data. Among the experimental models from
which CTCF ChIP-seq data deposited in ENCODE
were derived, HVMF is the only placenta-related cell
line. A view of chromosome 19 containing PSG genes
(chr19: 43 076 96–43 873 383) shows numerous CTCF
binding signals in many regions of the PSG gene body,
as well as in the upstream and downstream regions
(Fig. 1A). RNA-seq data show that several PSG genes
are expressed in the placental HVMF cell line. In the
enlarged genomic map, three strong CTCF binding
peaks are common to all PSG genes, except PSG3 and
PSG8, two of which are in the upstream region of
each gene (Fig. 1B). In addition to HVMF, these
peaks are highly conserved in various cell types,
including HUVEC, embryonic stem cells, and Hela
cells. One is located 1.6–1.8 kb upstream, and the
other is located 5.5–5.7 kb upstream from the tran-
scription start site (TSS) of each PSG gene. In the case
of PSG3 and PSG8, only one peak close to the TSS is
observed. Therefore, we focused on the proximal peak
close to the TSS observed in common in all PSG genes
and studied the location, orientation, and conservation
status of CBSs. As a result, we found three consensus
binding sequences for all 10 PSG genes, two being for-
ward orientation motifs and one being reverse orienta-
tion motif.
To investigate the role of CTCF in the regulation of
PSG gene expression, we needed an appropriate cell
line model in which all PSG genes were expressed, so
Fig. 1. Conserved CTCF occupancy in several different cell lines across the PSG gene loci. (A) Schematic representation of the PSG locus
containing the CBSs and amplicon sites in the cluster. A screen capture of the UCSC genome browser that shows the CTCF binding peaks
and RNA-seq signals of HVMF cell line in the genomic region of chr19: 43 076 96–43 873 383 that contained the PSG genes. (B) CBSs with
consensus sequences in the region 1.6–1.8 kb upstream of each PSG gene in various cell types (HVMF, H1-hESC, HUVEC, and Hela-S3).
Of the three consensus CTCF binding motifs, two showed forward orientation and the one closest to the TSS had reverse orientation.
Three consensus binding motifs showed a similar percentage of conservation.
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first analyzed the mRNA expression of 10 PSGs
(PSG1-PSG9, PSG11) from two different human tro-
phoblast cell lines, Swan 71 and JEG-3, by RT-PCR.
Unlike JEG3, the Swan71 cells were found to express
the entire set of PSG genes under normal conditions
(Fig. 2A), indicative of their applicability as an excel-
lent model system to study the role of specific factors
affecting gene expression at the site of PSG gene.
Although the expression of several PSG genes has been
previously identified in other trophoblast cell line and
primary placental cells [26,27], no studies have demon-
strated the expression of all human PSG genes in a par-
ticular cell line or tissue as shown in this study. On the
other hand, CTCF, known as a ubiquitously expressed
architectural protein, is well expressed in both tro-
phoblast cell lines, JEG-3 and Swan 71 (Fig. 2B,C).
Therefore, the ChIP experiment to examine CTCF
occupancy in the PSG gene locus was performed using
Swan 71 cells in consideration of the expression pattern
of the PSG genes. Based on the consensus sequence
motif shown in Fig. 1B, we designed amplicons for
ChIP-PCR to cover three binding sites in the upstream
region of each PSG gene. PCR primer sequences used
to amplify each amplicon site are listed in Table 1.
ChIP-PCR results showed that CTCF binds to the
upstream region of all PSG genes from PSG1 to
PSG11 throughout the locus (Fig. 2D).
To gain further evidence on whether CTCF con-
tributes to the transcription of the PSG gene cluster,
the mRNA level of each PSG gene was measured fol-
lowing the silencing of CTCF expression. The siRNA-
mediated KD of CTCF significantly downregulated
CTCF expression (Fig. 3A). In this condition, the
mRNA levels of PSG genes were affected; some PSG
genes, such as PSG1, PSG2, PSG4, PSG5, PSG8, and
PSG9, were upregulated, while PSG6 and PSG11
genes were downregulated (Fig. 3B). Under the CTCF
KD condition, CTCF binding was significantly
reduced at all PSG gene loci tested (Fig. 3C). These
results suggest that CTCF binding to the upstream
region of PSG genes is involved in the transcriptional
regulation of PSG genes. Our data also show that
CTCF binding exerts different effects on individual
PSG genes. In other words, the loss of CTCF binding
upregulates the expression of some PSG genes, while
downregulating the expression of others.
Fig. 2. The expression of PSG and CTCF in placental cells. (A) Comparison of PSG gene expression in Swan 71 and JEG-3 cells by RT-PCR.
b-Actin was used as an internal control for RT-PCR. (B) mRNA levels of CTCF in human placental cell lines. The number of each sample
indicates two biological replicates. (C) Protein levels of CTCF in human placental cell lines. (D) ChIP-PCR results for CTCF binding at the
designed amplicon sites in Swan 71 cells, which express the entire set of PSG genes. Primers for gene desert regions (chr20:57 828 313–
57 828 465) were used as negative control for ChIP-PCR.
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Next, to examine whether the CTCF KD-mediated
variation in PSG expression accompanies epigenetic
changes, we analyzed the modification patterns of his-
tone proteins enriched in the upstream regions of PSG
genes. As the promoter region of PSG genes is not
clearly defined from the current literature, we tried to
narrow down the scope of the interesting region by
evaluating the polymerase II (Pol2) binding position.
Three amplicon sites were generated by dividing the
1 kb upstream region from the TSS site of each PSG
Fig. 3. Effect of CTCF depletion on PSG gene expression in Swan 71 cells. (A) CTCF expression levels in siRNA-treated cells. (B) Fold
change in the expression level of PSG genes upon CTCF KD. The expression of each PSG indicates the relative level of the Ct value of the
siCTCF to the Ct of the siCON. All data were obtained from three separate experiments, and differences were represented as
mean  SEM. The Student’s t-test was used for comparison between siCTCF and siCON. Significant differences were considered as
*P < 0.05, **P < 0.01, ***P < 0.001. (C) ChIP-PCR results showing the decrease in CTCF binding at the proximal region of PSG genes
following CTCF expression KD.
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gene. PSG8 is presented as a representative gene
(Fig. 4A). PCR was performed using DNA obtained
by performing ChIP experiment with Pol2 antibody.
Of these sites, the P3 site showed the strongest binding
to Pol2 (Fig. 4B). Therefore, we analyzed for
H3K4me3 and H3K27me3 enrichment, targeting
approximately the same region in several other PSG
genes, including PSG8. PSG2 and PSG8 were selected
as the genes upregulated after CTCF KD, while PSG6
and PSG11 were chosen as the downregulated genes.
The increase in the level of PSG2 and PSG8 tran-
scripts after CTCF silencing was accompanied by an
increase in the recruitment of active mark H3K4me3
and a decrease in the recruitment of repressive mark
H3K27me3. The downregulation of PSG6 and PSG11
expression mediated by CTCF KD was consistent with
the enrichment of H3K27me3 rather than reduction of
H3K4me3 (Fig. 4C).
Together, our results provide evidence that CTCF
may regulate PSG gene expression via epigenetic
mechanisms. Keeping in mind that CTCF will define
the topological boundary of chromatin, CTCF defi-
ciency is expected to cause expression changes in the
same direction for all genes in the cluster, but our data
show that there are individual genes that are more par-
ticularly affected by CTCF deficiency. This suggests
that CTCF is likely to cooperate or counteract with
other transcription factors or cofactors bound to speci-
fic gene sites rather than acting alone when involved in
gene transcription. Considering that functional changes
are induced upon the manipulation of PSG expression,
as shown in previous studies [28], PSG deregulation by
CTCF shown in the present study may lead to dys-
function of PSG. On the other hand, apart from the
effect of CTCF expression level, a change in DNA
methylation pattern can affect the ability of CTCF to
bind to the target gene. During development, the
DNA methylation status of the placenta is the least
methylated unlike other tissues [29–31]. Abnormal reg-
ulation of placental DNA methylation is associated
with pregnancy disorders [32–35].
Thus, changes in DNA methylation patterns and dys-
regulated CTCF expression can both affect the expres-
sion of the PSG genes at developmental stages or
especially in complicated pregnancy. As mentioned ear-
lier, PSG is considered an important factor in maintain-
ing pregnancy based on several previous studies
showing its role in placental development, vascular mor-
phogenesis, and immunomodulation. While the specific
function of each PSG gene or its regulatory mechanism
is not yet known, our results demonstrating the role of
CTCF as a regulatory factor of PSG genes may take
one step closer to revealing the unknown field.
The next step in understanding how CTCF con-
tributes to structural changes in chromatin at the PSG
locus will be to explore the promoter and enhancer
regions involved in PSG gene transcription and further
investigate the changes in looping structure by CTCF.
Accumulation of relevant studies may answer whether
the CTCF-mediated spatial chromatin organization
contributes to the normal expression of the placental
PSG clustered gene family during pregnancy.
Fig. 4. Histone modification changes in
the promoter of PSG genes in response to
CTCF expression KD. (A) Genomic map of
PSG8 and amplicons for the detection of
Pol2 binding site. The 1 kb long-range
putative promoter region was divided into
three sites as follows: P1 (688 to 897),
P2 (551 to 707), and P3 (315 to
553). (B) ChIP-PCR result showing the
strongest Pol2 binding at P3 site.
Amplicon for gene desert region was
identical to that used in Fig. 2D. (C)
Changes in the enrichment of H3K4me3
active histone mark and H3K27me3
repressive mark at the PSG gene
promoter following CTCF expression KD.
To determine the binding pattern of each
histone mark, three biological replicates
were generated and analyzed.
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Conclusion
Our results showed that CTCF, which is known to
regulate the transcription of several clustered genes,
also may regulate the transcription of human PSG
genes (PSG1-PSG9, PSG11) in trophoblast cells.
Silencing of CTCF expression upregulated or down-
regulated the expression of several PSG genes, and
this effect was accompanied by epigenetic changes.
H3K4me3 was enriched in the promoter region of the
upregulated PSG genes, whereas H3K27me3 was
recruited to the promoter region of the genes with
reduced transcripts, such as PSG6 and PSG11. Fur-
ther studies are warranted to determine whether
CTCF mediates the communication between PSG
genes and regulatory elements and induces any alter-
ations in the chromatin structure. In conclusion, our
findings suggest that CTCF may be involved in the
transcriptional regulation of PSG genes once its
expression is induced and maintained in the placenta
during pregnancy.
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